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2Summary
This review provides an update on current evidence surrounding the epidemiology, treatment and
prevention of non-respiratory infections in care homes. It covers urinary tract infection (UTI),
methicillin-resistant staphylococcus aureus (MRSA), decubitus ulcers, scabies, tinea infections and
viral and bacterial gastroenteritis. The care home sector provides a unique ecological niche for
infections, housing frail older people with multiple co-morbidities and frequent contact with
healthcare services in a semi-closed environment. This leads to differences in the diagnosis and
management of infections – particularly of outbreaks – when compared with community-dwelling
counterparts. It is essential that care home staff play a role in the early recognition, isolation and
treatment of infections but they are often not trained as healthcare professionals – this presents a
challenge to systematised response. Effective interface between care homes, public health and
infection control services are essential to the delivery of care, yet it is not clear how most-effectively
to structure such links.
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3Introduction
Older people living in care homes are more dependent, have more co-morbidities and use health
services more than age-matched community-dwelling counterparts1, 2. As a consequence, they are
more vulnerable to infections and more likely to suffer significant sequelae3. Their living facilities
may provide both opportunities for transmission of infection and the possibility of early
identification and treatment4.
Pneumonia and influenza constitute the most important infections in care home residents in terms
of incidence, morbidity and mortality, and we have discussed these in a previous article5. We move
on here to discuss important non-respiratory infections in this cohort. As with our previous article,
we focus on considerations in the classification, epidemiology, diagnosis and management of these
which are particular, or particularly relevant, to the care home setting.
Search Strategy
We searched Medline (1950-present) to week 4 January 2010. We used the search terms “nursing
homes” OR “homes for the aged” OR “residential care facilities” AND “urinary tract infections” OR
“gastroenteritis” OR “colitis” OR “soft tissue infections” OR “skin infections”. We found 294 articles,
of which 7 were duplicate entries, 20 were not relevant to care homes and 2 were about children.
This left 265 articles which were read in full. Relevant publications from the reference lists of these
articles were also reviewed.
What is a care home?
A care home is defined in the United Kingdom (UK) as “an establishment [which] provides
accommodation, together with nursing or personal care, for persons who are or have been ill, who
have or have had a mental disorder, who are disabled or infirm, or are or have been dependent on
alcohol or drugs”6. All care homes provide support with activities of daily living but are classified as
either residential care homes or care homes with nursing depending on whether they provide
dedicated 24-hour professional nursing care. Considering the whole sector, only 8.6% of residents
4are <70, with 76% overall requiring assistance with their mobility or being immobile, 78% having at
least one form of mental impairment and 71% suffering incontinence2.
Although most developed countries have a care home equivalent, the model of separate residential
and nursing care is far from universal7, 8. Further, models of care differ between countries, ranging
from the highly medicalised, where medical support is provided in hospital-style surroundings, to the
highly socialised, where a primarily residential ethos is adopted, such as in the UK.
This residential ethos presents a number of challenges regarding infection control in the UK. Firstly
homes are small, with a mean number of residents of 36 in 20099, which facilitates containment of
infections but makes a structured response in the face of outbreaks difficult10. Secondly, most
homes are decorated with carpets and soft furnishings which are difficult to keep clean11. Finally, the
residential ethos of homes makes hospital-style isolation procedures difficult.
Not all aspects of the literature on infections in long-term care can readily be translated across
national boundaries. We attempt here to present findings of sufficient generalisability to be useful in
most contexts.
What is the prevalence of infection in care homes?
Data on the prevalence of infections in care homes come from the USA3, 12, 13, Norway14, 15,
Germany16, the Netherlands17 and Belgium18. These studies adopted differing designs, ranging from
point-prevalence studies to rolling surveillance programmes, identified and reported infections in
different ways and used different classification systems for infection. All were compromised by the
fact that acute infections resulting in hospital admission, such as viral gastroenteritis, are readily
identified whereas endemic but unobtrusive infections, such as tinea corporis, are not. Regardless of
these concerns, a clear hierarchy is evident with urinary tract infection (UTI) the most prevalent non-
respiratory infection, followed by soft tissue and gastrointestinal infections, as summarised in table
1.
5Table 1 – Point prevalence of common infections in care home populations(3, 13-15)
Type of infection Point prevalence (% of care home population)
Respiratory
Upper Respiratory Tract
Lower Respiratory Tract
0.3-3.7
0.13
0.3-1.6
Urinary Tract 0.6-21.8
Skin and Soft Tissue 1.0-8.8
Gastrointestinal 0.50
Urinary tract infections (UTI)
UTI is common amongst care home residents15, 19 and is a major source of antibiotic prescribing in
this group. Incidence and prevalence rates vary according to the diagnostic criteria used and
whether they include patients with asymptomatic bacteriuria or catheters20. A study in Californian
nursing homes using resident records and laboratory reports determined an incidence of 34.2%21,
whilst a prospective year–long surveillance study in a 103-bedded nursing home in Germany
reported an incidence of 1 infection per 1000 resident-days16. Point prevalence rates have been
reported at 1.58-3.8 in nursing homes13, 15. The prevalence of asymptomatic bacteriuria is much
higher, with rates of 15-50% in non-catheterised US residents of long term care facilities22 and
similar rates documented in other countries 23, 24.
Bacteriology
The commonest causes of UTI in older people are Escherichia coli and Proteus mirabilis22, 25.
However, care home residents more frequently experience UTI due to bacteria which are antibiotic-
resistant or more commonly associated with hospital infection, including Pseudomonas aeruginosa,
Klebsiella pneumoniae, Citrobacter spp. or Providencia stuartii26. This may, in part, be attributable to
the high incidence of antibiotic prescribing in the older population, with studies suggesting a strong
6link between the frequency with which an antibiotic is prescribed and subsequent antimicrobial
resistance amongst urinary pathogens25, 27.
Asymptomatic bacteriuria describes a positive urine culture, with or without pyuria and without
associated clinical symptoms. It is commoner in women, with advancing age28, is associated with
pyuria in over 90% of cases22, is inevitable in long-term catheterisation and has an incidence of 3-6%
per day with short-term catheters29. Treatment has no effect on mortality or incidence of
symptomatic infection and leads to morbidity from drug side effects and a higher incidence of
antimicrobial resistance22. The number needed to harm (NNH) for antibiotic treatment of
asymptomatic bacteriuria is 3 (95%CI 2-10)29.
Diagnosis
The diagnosis of UTI is frequently overestimated in care home residents30. Asymptomatic bacteriuria
should not be treated and symptomatic enquiry should therefore guide diagnosis. Symptoms are
commonly divided into lower urinary tract symptoms (LUTS) – dysuria, urgency and frequency – and
upper urinary tract symptoms (UUTS) – LUTS plus loin pain and fever.
Diagnostic criteria for UTI in residents of long term care facilities were developed in 2000 by a US
expert-consensus panel using a modified Delphi approach31. They suggested, for patients without a
catheter, that a UTI could be diagnosed on the basis of acute dysuria alone, or a fever of 37.9 ºC plus
any of new or worsening urgency, frequency, suprapubic pain, macroscopic haematuria, urinary
incontinence or costovertebral angle tenderness. In those with a catheter, LUTS were held to be
less useful and it was therefore suggested that diagnosis be on the basis of a fever of 37.9 ºC or 1.5
ºC over baseline, new costovertebral angle tenderness, rigors or new onset of delirium. It is likely,
however, that the false attribution of delirium to urinary tract infection because of the high
prevalence of asymptomatic bacteriuria results in much of the overtreatment previously described32
and these guidelines should therefore be applied with some degree of caution.
7A study of 551 non-catheterised nursing home residents found dysuria (RR 1.58 95%CI 1.10-2.03),
change in character of urine (RR 1.42 95%CI 1.07-1.79) and change in mental status (RR1.38 95%CI
1.03-1.74) to be associated with bacteriuria and pyuria33. Dysuria plus one or both other symptoms
was the highest predictor of bacteriuria/pyuria, and identified 63.2% of people with a UTI.
Obtaining samples
Obtaining samples of urine from care home residents may be difficult due to frailty, incontinence
and cognitive impairment. A mid-stream urine is non-invasive but is associated with a high
contamination rate which, contrary to received wisdom, is not reduced by cleansing the urethra with
water34. In men a urethral sheath can be used in patients who cannot produce a specimen whilst, in
women, an in-and-out catheter may be the best option22. Newcastle urine collection pads (UCPs)
represent a non-invasive way of collecting urine, however specimens collected from these are much
more useful for dipstick urinalysis than microbiological analysis35, 36.
Bedside tests
Bedside tests are useful only as an adjunct to clinical diagnosis. Visual inspection of urine has a
90.4% sensitivity but only a 66.4% specificity for bacteriuria, is dependent upon the experience of
the observer and is not, therefore, a useful test 29. Dipstick tests, meanwhile, are frequently positive
for leucocytes due to the high prevalence of asymptomatic bacteriuria in the care home population.
A dipstick positive for leucocytes and nitrites has a disappointingly low positive predictive value of
44%33. Dipstick tests can also miss UTI as a consequence of the fact that some organisms, including
Streptococcus pneumoniae, Enterococcus or Pseudomonas aeruginosa, do not express bacterial
nitrate reductase37 and are therefore of limited value in care homes. Men have a high incidence of
UTI secondary to organisms which may not form nitrites and should have urine sent for culture if
they have symptoms of UTI, regardless of dipstick result29. Dipstick tests should not be performed in
patients with long-term catheters as constant bacteriuria and pyuria means that the test is not
useful.
8Laboratory diagnosis
The threshold for laboratory diagnosis of UTI varies between countries. In the UK, 104 colony
forming units per ml (cfu/ml) is used as a lower threshold of a positive culture34. However, counts as
low as 102 cfu/ml may be accepted in women with definite symptoms of urinary tract infection
(“low-count” UTI) 29. In men, while there is less evidence to guide laboratory diagnosis , a lower cut-
off of 103 cfu/ml with 80% predominance of one organism may be diagnostic of UTI29. This is lower
than the current UK laboratory standard of 104 cfu/ml, and samples with 103 cfu/ml may be reported
“no significant growth”. Liaison with a microbiologist may be indicated if clinically a UTI is suspected
but a sample is negative.
In catheterized patients, surveillance cultures are not necessary and may lead to harm of the patient
through unnecessary treatment. Similarly, follow-up cultures after successful treatment are not
required34.
Prevention
A recent Cochrane review considering prevention of UTI suggested that antibiotic prophylaxis was
beneficial in non-pregnant patients29, 38. The benefit of antibiotics ceased after discontinuation.
However, the majority of studies were in younger patients and no studies were conducted
specifically in the care home setting. Further, the incidence of clostridium difficile enteritis in care
homes is high and the role of antibiotics in the aetiology of such infections well demonstrated.
The Scottish Intercollegiate Guideline Network (SIGN) suggest that high-dose cranberry tablets can
be used to prevent recurrent UTI29. Only one head-to-head trial has compared the effectiveness of
antibiotic prophylaxis with cranberry products, showing a modest but statistically non-significant
advantage for antibiotics, with a relative risk of symptomatic UTI during treatment of 1.62 in
the cranberry group compared with antibiotics39. The number needed to treat to prevent one
infection with cranberry is 6.4 compared with for 1.1 antibiotics but the number of adverse events is
9significantly lower40. Care is needed when advising cranberry for those on warfarin as the INR
(international normalized ratio) may be increased.
Oral oestrogens appear to be less effective than antibiotic prophylaxis and are not recommended for
prevention of UTI29. Vaginal oestrogens may be of some benefit.
Treatment
Women with LUTS may be treated with three day courses of antibiotics29, though some older
women will relapse and in this case longer courses of up to 10 days may be needed. A Cochrane
review compared single dose, 3-6 days and 7-9 days of antibiotic therapy for UTI and concluded that
3-6 days was associated with fewer adverse effects than longer courses but had similar benefits41.
Single dose therapy was least effective.
Men usually need longer courses of antibiotics (7-14 days) due to high rates of prostatic
involvement29. Some UTIs are described as “complicated” because bacteria are more difficult to
eradicate, and longer courses of antibiotics are necessary. Examples of abnormalities which cause
complicated UTI include renal or bladder stones, the presence of a urinary catheter, diabetes
mellitus, neurogenic bladder, bladder outflow obstruction and ureteric reflux, all of which are
common in care home residents. Because patients with catheters commonly present with multi-
resistant organisms, treatment should be given according to antibiotic sensitivities. If treatment
cannot be delayed, then antibiotic choice should take into account any previous positive urine
cultures.
SIGN guidelines recommend ciprofloxacin for 7 days as first line treatment for patients with UUTS
because of the possibility of bacteraemia29. Quinolones may be particularly useful in the care home
setting because they produce similar plasma levels whether given orally or intravenously37 and thus
can mitigate the need to admit to hospital. It should be noted that quinolones should not be used
for treatment of UTI in general due to a high associated incidence of clostridium difficile29 and
should probably only be commenced following discussion with a microbiologist.
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Men in care homes should be referred to urology if they fail to respond to antibiotics, develop two
UTIs within three months, or manifest UUTS29.
Skin and soft-tissue infections
The prevalence of skin infections is 1.0-8.8% amongst the care home population but they may
account for up to 50% of infections15, 20. Infections with Methicillin-Resistant Staphylococcus aureus
(MRSA), infected decubitus ulcers, scabies and tinea raise specific issues for consideration in the care
home setting.
Methicillin-Resistant Staphylococcus Aureus (MRSA)
22-23% of UK care home residents are colonised with MRSA42, 43, compared with 0.8% of community-
dwellers22 and 15% of hospital in-patients >6544, 45. Colonisation is seen in 1.1-35% of residents of
long-term care facilities depending on country46-50; though the reasons for such wide-ranging
prevalence are unclear, they may include institutional factors such as the frequency of transfer to
acute hospital, local infection control and antibiotic prescribing policies, and also the frequency of
instrumentation.
Patients colonized with MRSA have a higher mortality than those colonised with methicillin-sensitive
Staphylococcus aureus (MSSA), with an odds ratio of death of 1.93 (95% CI 1.54–2.42)51, though this
difference is less marked in the care home population than in hospitalised patients52 possibly due to
lower rates of instrumentation. Care-home residents are more likely to become colonized if they
have invasive devices (such as indwelling catheters or gastrostomy)53, decubitus ulcers54, have
previously been colonised with MRSA or have recently been on antibiotics55.
The interaction between reservoirs of MRSA in care homes and hospitals is well recognised with
recent transfer representing an independent risk factor for MRSA infection56-58. Failure to control
infection rates in one reservoir can overwhelm the other59 and controlling colonisation rates in care
homes has therefore been seen as possible way to influence infection rates in acute hospitals60.
Unfortunately, a Cochrane review revealed no evidence for effectiveness of eradication of MRSA
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using either topical or systemic antimicrobial therapy in any setting, including care homes61. A
second Cochrane review, which sought randomized-controlled trials evaluating barrier methods,
hand-washing or environmental hygiene in a care home setting, found no studies to meet its
inclusion criteria60. Clearly, further care home specific trials of MRSA-eradication and prevention
strategies are needed if a cogent argument is to be made that such measures are either effective or
beneficial.
Decubitus ulcers
Decubitus ulcers are common in care homes, with a prevalence of 11.9-39% compared to 8.3-23% of
acute hospital inpatients62. There is considerable international variation with prevalence being six
times higher, for example, in the Netherlands than in Germany, with no apparent explanation for the
difference63. Incidence rates are at their highest in the first few days following admission to a
home64, suggesting that many ulcers are sustained during acute admissions, prior to transfer to the
home, or in the recovery period immediately following acute illness. The higher prevalence of MRSA
and other antibiotic resistant organisms65 in care homes increases the likelihood that these ulcers
will become colonized by multi-resistant bacteria. MRSA is more virulent and more likely to cause
acute bacteraemia in active wounds such as decubitus ulcers than other bacteria50.
Signs of infection in pressure ulcers are erythema at the ulcer margin, malodour, new pain, warmth
or purulent discharge. The International Guidelines on Pressure Ulcer Management recommend that
infection be confirmed by either tissue biopsy or quantitative swab techniques before commencing
antibiotics66. Randomized controlled-trial level evidence to guide treatment is unavailable but
expert consensus suggests use of silver and iodine impregnated dressings as a first-line, with topical
antibacterial agents reserved for patients slow to respond66, 67. Systemic sepsis as a complication of
decubitus ulcer has a high mortality in the care home population, and physicians should have a low
threshold for instituting hospital admission in patients who develop signs of sepsis68.
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Osteomyelitis secondary to decubitus ulcer is significantly more likely in full-thickness ulcers
involving bone68. It cannot be diagnosed clinically in the care home setting, and when suspected,
patients should be admitted to hospital for definitive imaging, usually Magnetic Resonance Imaging,
followed by deep bone biopsy to guide treatment69. Clearly, such decisions need to be shaped by an
understanding of a resident’s overall prognosis.
Scabies
Scabies is common in care homes: in one survey of 179 Canadian long-term care facilities, 25%
reported a scabies outbreak over a 1-year period70. It is caused by irritation from the eggs, faeces
and saliva of the sarcoptes scabiei mite, which reproduces in the interdigital spaces of the hands and
feet, axillae and genital regions of infected patients. The usual response is for a patient to scratch,
killing the mite and therefore keeping the number of infesting organisms low.
The classical presentation is of intense pruritis, widespread papules, vesicles and excoriations and,
most characteristically, serpiginous burrows a millimetre or two in length in the interdigital spaces or
on the forearm. On close inspection, the lesion can sometimes be seen to have a burrow entrance,
with a vesicle (and sometimes a mite, visible as a black dot) at the opposite end71. Scabies can be
sexually transmitted and it is important to remember this as a differential diagnosis for genital
pruritis in the care home population72.
Norwegian, or crusted, scabies is a fulminant version of the infection, characterised by high levels of
infestation with thousands of mites on a single patient71 due to frailty, immunosenescence and a
reduced ability to scratch71, 73. A consequence of such high levels of infestation is the formation of
atypical crusted skin lesions which can be indistinguishable from psoriasis or eczema. Eosinophilia is
seen in just over half of cases, which may raise suspicion74. Serum IgE levels are increased in up to
98% of cases but this test is not routinely conducted in clinical practice.
Classical (non-Norwegian) scabies is contagious where there is prolonged skin-to-skin contact75,
which is common in care homes. Further, patients are often asymptomatic but contagious during the
13
3-week incubation period76 – during which time they could easily infect staff members or other
residents. Norwegian scabies is highly contagious because of the high parasite load and can spread
by even transient skin-to-skin contact73, 76.
Current guidelines tend to favour the use of topical permethrin on the basis of proven efficacy and a
favourable side-effect profile77, 78. Malathion is probably better tolerated but has less evidence
supporting its efficacy and, in particular, no head-to-head trial with permethrin is available78.
Effective application, with complete body coverage below the neck and concordance with treatment
is essential for efficacy – permethrin requires two applications lasting twelve hours and malathion,
one application lasting 24 hours. A key issue in care homes is that all residents with scabies, along
with all residents or staff who have had contact with them, are treated simultaneously – this in
practice often means treating all residents and staff in the home79.
Oral ivermectin is an effective but controversial treatment against scabies80 because of excess
deaths following treatment amongst 47 residents of a Canadian long-term care facility81. However,
most authorities assert that the treatment is safe, as these findings were not reproduced in cohorts
of 47 Colombian82 and 220 Dutch83 nursing home residents. It is available in the UK on a named
patient basis for treatment of Norwegian scabies77 but is not recommended by the Food and Drug
Administration in the US84.
Following treatment, the patient’s bedding and clothing should be washed at minimum 50°C and all
soft furnishings and carpets vacuumed77. The scabies mite is incapable of surviving outside of the
body for longer than 24 to 36 hours in conditions typically found in centrally-heated care homes85,
and is dependent on shed skin cells for survival, which are readily removed by modern vacuum
cleaners.
Tinea
Tinea pedis, corporis and capitis describe fungal infections of the feet, body and scalp respectively.
These are characteristically superficial skin infections of tricophyton or microsporum species and are
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usually sporadic and readily controlled by routine topical antifungal therapy86. Both outbreaks and
epidemics of tinea have been described in care homes 87, 88 and involved atypical fungal organisms,
spread by staff and personal hygiene utensils (combs and razors). Staff also contracted the infection.
Staff therefore need to ensure both prompt medical attention and close attention to barrier nursing
methods when index cases of tinea are identified.
Gastrointestinal infections
Although the incidence of gastroenteritis is relatively low in older patients, care home residents are
much more likely than their community-dwelling counterparts to be hospitalised or die as a
consequence of infection89. A US review conducted 1995-1997 reported the death rate in nursing
home residents due to gastroenteritis as 38.91 (95% CI, 38.55–39.27) per 100,000 persons,
compared with 8.50 (95% CI, 8.47–8.53) for all over-65s90. Gasteroenteritis can be split into viral
and bacterial aetiology, with special consideration given to Clostridium difficile given its high
mortality in this group.
Viral gastroenteritis
Epidemiology
The incidence of viral gastroenteritis, of which the two most common causes are norovirus
(synonyms “Norwalk-like viruses” and “small, round-structured viruses”) and rotavirus, considerably
outstrips that of bacterial gastrointestinal infections in care homes91. In 2006, norovirus was the
cause of 96% of acute gastroenteritis outbreaks in the US. Of these, 50% of the non-food related
outbreaks occurred in long-term care facilities92. In Europe, 34-39% of norovirus outbreaks occur in
care homes93, 94.
Norovirus infections in care homes are commonly associated with person-to-person spread,
predominantly via the faecal oral route, even when the index case is acquired from food92, 95. A
characteristic winter peak in incidence occurs, which coincides almost exactly with the winter peak
in respiratory infections94.
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Diagnosis
Kaplan et al 96 suggested that viral gastroenteritis can be diagnosed clinically and is characterised by
a short incubation period (24-60 h), a short infection duration (12–60 h) and a high frequency of
vomiting (>50% of cases). These criteria are, however, based upon studies in healthy volunteers and
critics suggest that infections are both less typical and less benign in care home residents94.
Infection Control
Because norovirus is environmentally very stable, difficult to eradicate and highly infectious,
particular attention is required to infection control measures. Chadwick et al97 provided useful
recommendations for the containment of norovirus outbreaks in the hospital setting, most of which
also apply to the care home setting, and these are summarised in box 1.
Box 1: Measures for containment of norovirus infection, from Chadwick et al(97)
 Isolate or cohort symptomatic residents.
 Wear gloves and apron for contact with affected patients and change these between
patients.
 Wash hands with soap and water after contact with an affected patient.
 Exclude affected staff from duties until symptom-free for 48 hours.
 Close of the facilities to new admissions.
 Limit visits and advise visitors on handwashing.
 Promptly clean body fluid spillages.
 Increase the frequency of routine cleaning.
 Use 0.1% (1000 ppm) hypochlorite to disinfect hard surfaces and clean soft furnishings with
either steam or detergent and hot water.
Chlorhexidine and alcohol are ineffective against norovirus and therefore bleach must be used for
cleansing surfaces, and soap and water for washing hands97, 98. Staff must wear protective clothing
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during contact with infected residents, as exposure to vomitus increases the risk of contracting the
illness, though concordance with wearing gowns in particular appears poor 95.
Isolation and cohorting of residents can prove difficult in care homes due to shared bathroom
facilities and wandering residents. Minimising the amount of time for which residents are isolated
helps considerably. For norovirus, viral shedding in stool normally peaks between 24 and 72 hours99
but can last longer, and has been reported up to 45 days following resolution of symptoms in care
home residents100. On the basis of pragmatism, most authors recommend isolating patients for 48-
72 hours after symptom resolution98.
The recommendation that staff be excluded from work for 48 hours following resolution of
symptoms is similarly pragmatic, however longer periods of staff exclusion may be both desirable
and cost-effective. A UK case-control study comparing staff exclusion for either 48 or 72 hours
showed significantly lower infection and attack rates in the 72 hour group and suggested that the
net effect on staff availability was minimal101. Staff education and a no-blame culture are essential to
maintain staff compliance with such protocols, as staff presenteeism during illness is common 95.
Treatment
Much of the excess morbidity and mortality associated with viral gastroenteritis in the care home
cohort is likely to be due to the effects of dehydration94 and treatment largely focuses on avoiding
this. UK care homes are unable to provide intravenous fluids and such therapy necessitates transfer
to hospital. Clearly such transfer is problematic both because it spreads infection and exposes a frail
patient to the risks of the acute hospital. An alternative is to use antimotility drugs, such as
loperamide or racecadotril102, whilst pursuing aggressive oral rehydration.
Food-borne gastroenteritis
Food-borne gastroenteritis outbreaks can readily take place in care homes because food is often
prepared in a central kitchen and served communally, and outbreaks due to Bacillus cereus103,
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Salmonella enteritidis104 and verotoxin producing Escherichia coli serotype O157105 have been
described. Depending on the organism, these outbreaks can either be self-limiting or perpetuated
by person-to-person spread. The potential for spread is greater in care homes than in the
community due to the combination of close contact between residents and the high rates of faecal
incontinence, especially during diarrhoeal illness. E. coli O157 is particularly important because of its
association with haemolytic uraemic syndrome and excess mortality is reported over the age of
50106. It can present non-specifically in care home residents, with visible bloody diarrhoea in only 65-
75% of patients106. Of the four outbreaks reported in the literature, the rate of conversion to
haemolytic uraemic syndrome ranges from 0-14.2% and the mortality rate from 3-14.2% 106-110.
Clostridium difficile enteritis
Residence in a care home, especially in the first year after admission, is an independent risk factor
for Clostridium difficile infection, which occurs in 7-9% of residents compared with 2% of healthy
adults111. Reasons for this include high levels of antibiotic prescribing, the increased incidence of
proton-pump inhibitor mediated achlorhydia and the frailty of care home residents111, 112. Once
established in a home, clostridium difficile can spread via the faecal-oral route and through contact
with contaminated surfaces and attention to isolation measures is, again, important. Handwashing
using soap and surface cleansing using hypochlorite based substances are essential because these,
unlike alcohol, are sporicidal112.
Generic issues around gastroenteritis in care homes
Analysis of stool specimens is particularly important in care home residents because it allows correct
selection of treatment with loperamide, for example, which is best avoided in haemorrhagic E. coli
or Clostridium difficile infections113 but represents an important therapy in viral gastroenteritis. It
also allows epidemiological analysis of infections to identify the infecting strain of each organism and
track its spread.
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Regardless of the cause of enteritis, it is likely that the early parts of recognition and management
will be conducted without input from a doctor or possibly even a nurse. Thus, operational definitions
for gastroenteritis outbreaks are essential98, 104. These should, ideally, be written in lay language and
presented alongside clear guidelines about early isolation, specimen collection and fluid
management. Such guidelines are not, at present, universally available.
Conclusion
Because of the concentration of frail older people in a semi-closed environment, care homes present
particular challenges in the diagnosis and management of infection. Infections which are frequently
inconsequential in community-dwelling adults can be life-threatening in care home residents, as is
the case with UTI. Infections can also behave in atypical ways in this cohort, as is the case with
Norwegian scabies or epidemic tinea.
A further challenge when dealing with such frail patients is deciding when to admit them to acute
hospital care – which is fraught with risk. There is often an alternative, for example by using
intramuscular antibiotics or oral quinolones for UTI, or by using antimotility agents in viral
gastroenteritis. Occasionally, however, there is none, for example the need for detailed imaging and
bone biopsy in suspected osteomyelitis complicating decubitus ulcer. When such difficult decisions
are required they should be made with attention to the patient’s overall prognosis and stated
wishes.
At an individual home level, prompt recognition and treatment coupled to rigorous infection control
are needed to minimise the impact of infection. The fact that care, in the UK at least, is often
provided by staff without healthcare qualifications is a challenge to such systematic response.
Consideration must be given as to what role care home staff can and should play. Guidelines for the
sector should be written with them in mind and, almost certainly, with their input.
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At a public health level, antibiotic stewardship and improved links from homes to microbiology and
infection control services seem intuitive responses. How to provide such support consistently to a
highly heterogeneous sector is a genuine challenge for health service providers and an area for
research and development going forward.
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